THERMO FISHER SCIENTIFIC INC (TMO) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:TMO • US8835561023

565.22 USD
-4.87 (-0.85%)
At close: Feb 4, 2026
565.23 USD
0.01 (0%)
Pre-Market: 2/5/2026, 5:41:19 AM
Fundamental Rating

4

Overall TMO gets a fundamental rating of 4 out of 10. We evaluated TMO against 57 industry peers in the Life Sciences Tools & Services industry. While TMO is still in line with the averages on profitability rating, there are concerns on its financial health. TMO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • TMO had positive earnings in the past year.
  • In the past year TMO had a positive cash flow from operations.
  • Each year in the past 5 years TMO has been profitable.
  • TMO had a positive operating cash flow in each of the past 5 years.
TMO Yearly Net Income VS EBIT VS OCF VS FCFTMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.08%, TMO belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 12.55%, TMO belongs to the top of the industry, outperforming 85.96% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.80%, TMO is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for TMO is significantly below the industry average of 13.78%.
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROIC 7.8%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)8.04%
ROIC(5y)9.02%
TMO Yearly ROA, ROE, ROICTMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TMO's Profit Margin of 15.05% is amongst the best of the industry. TMO outperforms 84.21% of its industry peers.
  • In the last couple of years the Profit Margin of TMO has declined.
  • Looking at the Operating Margin, with a value of 18.19%, TMO belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
  • In the last couple of years the Operating Margin of TMO has declined.
  • TMO has a Gross Margin (41.22%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of TMO has declined.
Industry RankSector Rank
OM 18.19%
PM (TTM) 15.05%
GM 41.22%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-0.55%
GM growth 5Y-3.49%
TMO Yearly Profit, Operating, Gross MarginsTMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

3

2. Health

2.1 Basic Checks

  • TMO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TMO has less shares outstanding
  • TMO has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TMO has a worse debt to assets ratio.
TMO Yearly Shares OutstandingTMO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TMO Yearly Total Debt VS Total AssetsTMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • The Debt to FCF ratio of TMO is 6.26, which is on the high side as it means it would take TMO, 6.26 years of fcf income to pay off all of its debts.
  • TMO has a better Debt to FCF ratio (6.26) than 66.67% of its industry peers.
  • TMO has a Debt/Equity ratio of 0.67. This is a neutral value indicating TMO is somewhat dependend on debt financing.
  • TMO's Debt to Equity ratio of 0.67 is on the low side compared to the rest of the industry. TMO is outperformed by 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Altman-Z N/A
ROIC/WACC0.71
WACC11.02%
TMO Yearly LT Debt VS Equity VS FCFTMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that TMO should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.89, TMO is not doing good in the industry: 61.40% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.53 indicates that TMO should not have too much problems paying its short term obligations.
  • The Quick ratio of TMO (1.53) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.53
TMO Yearly Current Assets VS Current LiabilitesTMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

  • TMO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.62%.
  • Measured over the past 5 years, TMO shows a small growth in Earnings Per Share. The EPS has been growing by 3.19% on average per year.
  • Looking at the last year, TMO shows a small growth in Revenue. The Revenue has grown by 3.91% in the last year.
  • TMO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%

3.2 Future

  • Based on estimates for the next years, TMO will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.96% on average per year.
  • Based on estimates for the next years, TMO will show a small growth in Revenue. The Revenue will grow by 4.93% on average per year.
EPS Next Y8.54%
EPS Next 2Y9%
EPS Next 3Y9.51%
EPS Next 5Y10.96%
Revenue Next Year5.68%
Revenue Next 2Y5.47%
Revenue Next 3Y5.78%
Revenue Next 5Y4.93%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TMO Yearly Revenue VS EstimatesTMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TMO Yearly EPS VS EstimatesTMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 24.71, which indicates a rather expensive current valuation of TMO.
  • Based on the Price/Earnings ratio, TMO is valued a bit cheaper than the industry average as 75.44% of the companies are valued more expensively.
  • TMO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.25.
  • Based on the Price/Forward Earnings ratio of 22.77, the valuation of TMO can be described as rather expensive.
  • TMO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TMO is cheaper than 77.19% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, TMO is valued at the same level.
Industry RankSector Rank
PE 24.71
Fwd PE 22.77
TMO Price Earnings VS Forward Price EarningsTMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 68.42% of the companies in the same industry are more expensive than TMO, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, TMO is valued a bit cheaper than the industry average as 70.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 33.74
EV/EBITDA 22.17
TMO Per share dataTMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of TMO may justify a higher PE ratio.
PEG (NY)2.9
PEG (5Y)7.76
EPS Next 2Y9%
EPS Next 3Y9.51%

6

5. Dividend

5.1 Amount

  • TMO has a yearly dividend return of 0.30%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.09, TMO pays a better dividend. On top of this TMO pays more dividend than 84.21% of the companies listed in the same industry.
  • With a Dividend Yield of 0.30, TMO pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

  • On average, the dividend of TMO grows each year by 14.69%, which is quite nice.
  • TMO has paid a dividend for at least 10 years, which is a reliable track record.
  • TMO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)14.69%
Div Incr Years7
Div Non Decr Years12
TMO Yearly Dividends per shareTMO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 9.49% of the earnings are spent on dividend by TMO. This is a low number and sustainable payout ratio.
  • TMO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.49%
EPS Next 2Y9%
EPS Next 3Y9.51%
TMO Yearly Income VS Free CF VS DividendTMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
TMO Dividend Payout.TMO Dividend Payout, showing the Payout Ratio.TMO Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

NYSE:TMO (2/4/2026, 8:04:00 PM)

Premarket: 565.23 0.01 (0%)

565.22

-4.87 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners92.78%
Inst Owner Change-2.39%
Ins Owners0.1%
Ins Owner Change4.84%
Market Cap212.36B
Revenue(TTM)44.56B
Net Income(TTM)6.70B
Analysts83.13
Price Target678.16 (19.98%)
Short Float %1.04%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend1.68
Dividend Growth(5Y)14.69%
DP9.49%
Div Incr Years7
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.64%
Min EPS beat(2)0.91%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.7%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)6
Avg EPS beat(8)2.42%
EPS beat(12)7
Avg EPS beat(12)1.02%
EPS beat(16)11
Avg EPS beat(16)2.83%
Revenue beat(2)2
Avg Revenue beat(2)1.08%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.21%
Revenue beat(4)4
Avg Revenue beat(4)0.77%
Min Revenue beat(4)0.28%
Max Revenue beat(4)1.21%
Revenue beat(8)6
Avg Revenue beat(8)0.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.27%
Revenue beat(16)11
Avg Revenue beat(16)1.95%
PT rev (1m)2.38%
PT rev (3m)5.93%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 24.71
Fwd PE 22.77
P/S 4.77
P/FCF 33.74
P/OCF 27.16
P/B 3.98
P/tB N/A
EV/EBITDA 22.17
EPS(TTM)22.87
EY4.05%
EPS(NY)24.82
Fwd EY4.39%
FCF(TTM)16.75
FCFY2.96%
OCF(TTM)20.81
OCFY3.68%
SpS118.59
BVpS142.17
TBVpS-31.37
PEG (NY)2.9
PEG (5Y)7.76
Graham Number270.48
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROCE 8.52%
ROIC 7.8%
ROICexc 8.73%
ROICexgc 37.4%
OM 18.19%
PM (TTM) 15.05%
GM 41.22%
FCFM 14.13%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)8.04%
ROIC(5y)9.02%
ROICexc(3y)8.83%
ROICexc(5y)9.85%
ROICexgc(3y)40.31%
ROICexgc(5y)46.65%
ROCE(3y)8.78%
ROCE(5y)9.93%
ROICexgc growth 3Y-13.91%
ROICexgc growth 5Y-12.87%
ROICexc growth 3Y-6.93%
ROICexc growth 5Y-10.12%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-0.55%
GM growth 5Y-3.49%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Debt/EBITDA 3.29
Cap/Depr 54.86%
Cap/Sales 3.42%
Interest Coverage 250
Cash Conversion 71.83%
Profit Quality 93.88%
Current Ratio 1.89
Quick Ratio 1.53
Altman-Z N/A
F-Score5
WACC11.02%
ROIC/WACC0.71
Cap/Depr(3y)47.77%
Cap/Depr(5y)61.4%
Cap/Sales(3y)3.38%
Cap/Sales(5y)4.31%
Profit Quality(3y)108.05%
Profit Quality(5y)102.29%
High Growth Momentum
Growth
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
EPS Next Y8.54%
EPS Next 2Y9%
EPS Next 3Y9.51%
EPS Next 5Y10.96%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%
Revenue Next Year5.68%
Revenue Next 2Y5.47%
Revenue Next 3Y5.78%
Revenue Next 5Y4.93%
EBIT growth 1Y5.05%
EBIT growth 3Y-1.59%
EBIT growth 5Y0.61%
EBIT Next Year19.29%
EBIT Next 3Y11.41%
EBIT Next 5Y10.61%
FCF growth 1Y-13.39%
FCF growth 3Y-3.07%
FCF growth 5Y-1.58%
OCF growth 1Y-9.78%
OCF growth 3Y-5.12%
OCF growth 5Y-1.16%

THERMO FISHER SCIENTIFIC INC / TMO FAQ

What is the ChartMill fundamental rating of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TMO.


What is the valuation status of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a valuation rating of 4 / 10 to THERMO FISHER SCIENTIFIC INC (TMO). This can be considered as Fairly Valued.


What is the profitability of TMO stock?

THERMO FISHER SCIENTIFIC INC (TMO) has a profitability rating of 6 / 10.


What is the financial health of THERMO FISHER SCIENTIFIC INC (TMO) stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TMO) is 3 / 10.


What is the expected EPS growth for THERMO FISHER SCIENTIFIC INC (TMO) stock?

The Earnings per Share (EPS) of THERMO FISHER SCIENTIFIC INC (TMO) is expected to grow by 8.54% in the next year.